The Randomized Double-blind Controlled Clinical Trial of Combination of Intravitreal Ranibizumab With or Without Macular Laser Photocoagulation for Macular Edema Secondary to Branch Retinal Vein Occlusion
Latest Information Update: 30 Dec 2022
At a glance
- Drugs Ranibizumab (Primary)
- Indications Branch retinal vein occlusion; Retinal oedema
- Focus Therapeutic Use
- 25 Dec 2022 Status changed from discontinued to completed.
- 19 Jan 2020 Status changed from not yet recruiting to discontinued.
- 20 Feb 2017 New trial record